Nimitz Health

Nimitz Health

Your guide to health policy in Washington, DC

Archive

“383 Trials” vs. “A Dozen”: Inside the NIH Hearing That Split the Room

“383 Trials” vs. “A Dozen”: Inside the NIH Hearing That Split the Room

Clinical trials, vaccines, trust—and why the numbers mattered more than the rhetoric.

RFK Jr. is Rewriting the Playbook

RFK Jr. is Rewriting the Playbook

As Washington remains partially shut down, vaccine policy, addiction strategy, and drug pricing are all in flux.

Where Are Your Generics Really Made?

Where Are Your Generics Really Made?

Senators pressed FDA gaps, China/India exposure, and a push for origin labels plus QR-linked data.

ICYMI: Who Really Controls Health Care?

ICYMI: Who Really Controls Health Care?

Lawmakers pressed insurance company executives on premiums, denials, consolidation, and patient harm.

Shutdown Season is Back (Did It Ever Leave?)

Shutdown Season is Back (Did It Ever Leave?)

Senate Democrats are blocking the DHS/HHS/Defense funding bill after a Minneapolis shooting, pushing Congress toward a shutdown deadline.

The Health Care Monopoly Problem

The Health Care Monopoly Problem

Consolidation took center stage at the House Budget Hearing. From dominant PBMs to hospital market power fueling higher prices, patients' choices are increasingly limited.

HHS Reversals, Vaccine Tensions, and a Funding Sprint

HHS Reversals, Vaccine Tensions, and a Funding Sprint

The new week opens with must-pass funding, behavioral health uncertainty, and major signals on vaccines and GLP-1s.

Mifepristone Showdown

Mifepristone Showdown

Senators clashed over safety evidence, adverse-event reporting, and whether telehealth/mail-order access should be rolled back.

This Week in Health Policy

This Week in Health Policy

Appropriations brinkmanship, ACA subsidy negotiations, and the next wave of AI oversight.

New Year, Same Vaccine Debates

New Year, Same Vaccine Debates

HHS is reshaping parts of the childhood schedule and shifting some decisions back to clinicians—expect ripple effects for uptake, coverage, and state implementation.

News Flash: Inside Congress’s Latest PFAS Liability Showdown

News Flash: Inside Congress’s Latest PFAS Liability Showdown

Members and witnesses debated whether CERCLA’s strict liability framework is deterring cleanup and redevelopment or remains essential to holding PFAS polluters accountable, with implications for water rates, brownfields, and downstream communities.

Sleigh Bells & Subsidies: DC’s Health Cliffhanger

Sleigh Bells & Subsidies: DC’s Health Cliffhanger

It’s a mad dash before the holiday recess, and ACA premiums are on the chopping block.

FirstBack
123456
Next Last